← Tra cứu cổ phiếu
Viewing Quý 1/2026Latest period →

iShareInvest Research

HNX · Quý 1/2026

PPP

Dược phẩm Phong Phú

Analysis of business results & financial statements · Quý 1/2026

▲▲ Improving positively

Trailing net profit reached 24.8bn, rose 5.6bn compared with the same period last year. Key positives came from better other profit and higher gross profit. Offsetting pressure came mainly from higher tax, higher administrative expenses, and higher selling expenses. Detailed impact is shown below:

See what is changing ↓
P/E
7.82x
P/B
1.17x
EPS
2,532
BVPS
16,872
ROE
17.3%
ROA
14.0%
Market price
19,800
19 Oct 2026

What Is Changing

On a TTM 2026Q1 basis, PPP has not accelerated revenue sharply, but profitability is improving visibly — the growth momentum has held across consecutive periods. Profit growth is driven mainly by better operations rather than scale expansion — a foundation that tends to be more durable.

Profit bridge

Vs last year · TTM

  1. Other profit
  2. Gross profit
  3. Tax
  4. Administrative expenses
  5. Selling expenses
Unit: VND bn. Green bars support profit; red bars reduce profit.

A single data point, or a trajectory?

Latest eight quarters · Quý 1/2026

MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24
Revenue37.441.332.531.134.936.533.436.9
LNST10.86.43.34.34.55.44.74.6
Net margin28.88%15.55%10.09%13.90%12.97%14.88%14.09%12.48%

Revenue

37bn

Net income

11bn

Net margin

28.88%

A closer look at what is happening inside the business

A company's statements are read with the questions that fit its type of business.

01

Is the profit sustainable?

Margins are improving and earnings quality is solid — a durable foundation for ROE.

What is driving the margin?

▲▲

Net margin expanded to 17.45%, rising 3.8pp. Core operating signals are improving as Gross margin rose 2.0pp are enough to offset pressure from SG&A / Revenue rose 1.7pp (with additional support from Other profit / Revenue rose 4.2pp and Net financial result / Revenue rose 0.2pp).

Most of the margin increase comes from non-core items — core operations have not kept pace, this is a margin expansion to watch carefully.

Net Margin
17.45%
+3.8pp
Gross Margin
36.48%
+2.0pp
SG&A / Revenue
20.16%
+1.7pp

TTM YoY · 2025Q1 -> 2026Q1

02

Is capital being used efficiently?

Capital efficiency should be read in industry context — ROIC may fluctuate with business specifics.

Is capital being deployed efficiently?

●

Track how much operating profit the business generates on invested capital.

Industry characteristics make ROIC cyclical — this is a reference signal and should be read with the business context.

Balance Sheet

▲

ROIC above should be read with industry context — the balance sheet below adds perspective. Balance sheet is exceptionally sound — liabilities at 0.27x equity, with a net cash position equivalent to 0.03x equity.

Inventory ended the period at 40.1bn, roughly 22.7% of total assets.

Over the last 12 months, working capital released 0.6bn of cash, mainly thanks to lower receivables and higher payables. Pressure from higher inventories only partly offset that benefit.

Working Capital Efficiency

▼

Cash conversion cycle lengthened by 11.1 days versus the same period last year. The main moves came from DIO rose 17.1 days, DSO fell 2.9 days, and DPO rose 3.0 days.

Working capital cycle lengthened mainly due to slower inventory turnover — more capital is being tied up in inventory.

Cash conversion cycle remains stretched

CCC stands at 135.9 days, suggesting that working capital remains tied up for a relatively long operating cycle.

Inventory turnover is slowing

DIO increased by +17.1 days, suggesting more capital is being tied up in inventories.

DuPont

What drives ROE?

Net margin 17.4% +3.8pp
Asset turnover 0.80x -0.06x
Financial leverage 1.23x +0.03x
ROE 17.3% +3.1pp

ROE rose from 14.2% to 17.3% — mainly driven by net margin, despite asset turnover moving in the opposite direction.

03

Is financial risk significant?

Financial risk is low — the company has net cash and CFO reached 16.8bn.

Leverage & Liquidity

▲

Leverage looks fairly comfortable, with net debt / equity at −0.03x and interest coverage at 141.51x.

At present, short-term debt accounts for 100.0% of total debt, cash equals 215.3% of debt, and total debt stands at 3.7bn.

Short-term refinancing pressure is meaningful

Short-term debt accounts for 100.0% of total debt, raising near-term refinancing needs.

Net Debt / Equity
−0.03x
Interest Coverage
141.51x
−467.85x
Cash / Debt
215.3%
Short-term Debt / Total Debt
100.0%

TTM YoY · 2025Q1 -> 2026Q1

Cash Flow

▲▲

With safe leverage noted above, cash flow below shows the self-funding capacity. Operating cash flow reached 16.8bn in 2025, against investing cash flow of -9.2bn.

Post-investment cash flow was positive +7.6bn. Financing cash flow was negative +6.9bn.

CFO / net income was 1,04 lần.

After spending +1.5bn on fixed-asset investment, the business generated trailing free cash flow of +24.3bn.

Research synthesis

What this reporting period is showing

The business is heading the right way, but the current picture is still at partial confirmation — not yet a fully clean case. The positive points have clearly improved, showing the operating base is better than before. The brighter spot is operating efficiency, with net margin improving 3.8 pp. The next item to monitor is the earnings mix, when non-core contribution is 20.1%. The main risk still sits in working capital is tied up too long in the operating cycle, with CCC extended to 136 days.

  • Improvement: operating efficiency is getting better, with trailing-12M net margin at 17.45% after expanding 3.8pp versus the same period last year.
  • Watchpoint: cash flow is currently keeping pace with accounting earnings, with CFO / net income at 1.04x. Even so, net financial result still accounts for 20.1% of PBT, so the earnings mix still needs monitoring.
  • Key risk: working capital remains tied up for too long, with cash cycle at 135.9 days.

Questions for the next period

  1. Durability of revenue growth after the current +0,5% YoY pace.

  2. Ability to hold margins around the current 17.45% level.

  3. Cash-flow quality, with operating cash flow currently at 16.8bn in 2025.

From one stock to the whole portfolio

Where does this stock stand
among the rest of your investments?

Each stock is only one part of the wider picture. Looking at investments side by side makes their contribution, risks and opportunities across the portfolio clearer.

How much does this stock
contribute to the portfolio?

Its weight and influence across the assets held for investment.

Is the portfolio
well balanced?

How holdings, sectors and asset groups are distributed in relation to overall risk.

What other opportunities
or risks may be present?

What becomes visible only when investments are viewed together rather than one ticker at a time.

View my portfolio